| UniProt ID | BAIP2_HUMAN | |
|---|---|---|
| UniProt AC | Q9UQB8 | |
| Protein Name | Brain-specific angiogenesis inhibitor 1-associated protein 2 | |
| Gene Name | BAIAP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 552 | |
| Subcellular Localization |
Cytoplasm. Membrane Peripheral membrane protein. Cell projection, filopodium. Cell projection, ruffle. Cytoplasm, cytoskeleton. Detected throughout the cytoplasm in the absence of specific binding partners. Detected in filopodia and close to membran |
|
| Protein Description | Adapter protein that links membrane-bound small G-proteins to cytoplasmic effector proteins. Necessary for CDC42-mediated reorganization of the actin cytoskeleton and for RAC1-mediated membrane ruffling. Involved in the regulation of the actin cytoskeleton by WASF family members and the Arp2/3 complex. Plays a role in neurite growth. Acts syngeristically with ENAH to promote filipodia formation. Plays a role in the reorganization of the actin cytoskeleton in response to bacterial infection. Participates in actin bundling when associated with EPS8, promoting filopodial protrusions.. | |
| Protein Sequence | MSLSRSEEMHRLTENVYKTIMEQFNPSLRNFIAMGKNYEKALAGVTYAAKGYFDALVKMGELASESQGSKELGDVLFQMAEVHRQIQNQLEEMLKSFHNELLTQLEQKVELDSRYLSAALKKYQTEQRSKGDALDKCQAELKKLRKKSQGSKNPQKYSDKELQYIDAISNKQGELENYVSDGYKTALTEERRRFCFLVEKQCAVAKNSAAYHSKGKELLAQKLPLWQQACADPSKIPERAVQLMQQVASNGATLPSALSASKSNLVISDPIPGAKPLPVPPELAPFVGRMSAQESTPIMNGVTGPDGEDYSPWADRKAAQPKSLSPPQSQSKLSDSYSNTLPVRKSVTPKNSYATTENKTLPRSSSMAAGLERNGRMRVKAIFSHAAGDNSTLLSFKEGDLITLLVPEARDGWHYGESEKTKMRGWFPFSYTRVLDSDGSDRLHMSLQQGKSSSTGNLLDKDDLAIPPPDYGAASRAFPAQTASGFKQRPYSVAVPAFSQGLDDYGARSMSRNPFAHVQLKPTVTNDRCDLSAQGPEGREHGDGSARTLAGR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSLSRSEEM ------CCCCHHHHH | 34.74 | 22617229 | |
| 2 (in isoform 5) | Phosphorylation | - | 34.74 | 24719451 | |
| 4 | Phosphorylation | ----MSLSRSEEMHR ----CCCCHHHHHHH | 26.84 | 23090842 | |
| 6 | Phosphorylation | --MSLSRSEEMHRLT --CCCCHHHHHHHHH | 34.24 | 23090842 | |
| 17 | Phosphorylation | HRLTENVYKTIMEQF HHHHHHHHHHHHHHH | 17.62 | 25106551 | |
| 38 | Phosphorylation | FIAMGKNYEKALAGV HHHCCCCHHHHHHHH | 23.46 | 29496907 | |
| 40 | Ubiquitination | AMGKNYEKALAGVTY HCCCCHHHHHHHHHH | 38.04 | - | |
| 52 | Phosphorylation | VTYAAKGYFDALVKM HHHHHHHHHHHHHHH | 9.51 | - | |
| 58 | Ubiquitination | GYFDALVKMGELASE HHHHHHHHHHHHHHC | 41.88 | - | |
| 70 | Ubiquitination | ASESQGSKELGDVLF HHCCCCCHHHHHHHH | 64.88 | 21906983 | |
| 70 (in isoform 1) | Ubiquitination | - | 64.88 | 21906983 | |
| 70 (in isoform 2) | Ubiquitination | - | 64.88 | 21906983 | |
| 70 (in isoform 3) | Ubiquitination | - | 64.88 | 21906983 | |
| 70 (in isoform 4) | Ubiquitination | - | 64.88 | 21906983 | |
| 70 (in isoform 5) | Ubiquitination | - | 64.88 | 21906983 | |
| 70 (in isoform 6) | Ubiquitination | - | 64.88 | 21906983 | |
| 96 | Phosphorylation | QLEEMLKSFHNELLT HHHHHHHHHHHHHHH | 27.98 | 20068231 | |
| 108 | Ubiquitination | LLTQLEQKVELDSRY HHHHHHHHHHHCHHH | 28.44 | - | |
| 115 | Phosphorylation | KVELDSRYLSAALKK HHHHCHHHHHHHHHH | 14.68 | 28152594 | |
| 121 | Ubiquitination | RYLSAALKKYQTEQR HHHHHHHHHHHHHHH | 44.71 | - | |
| 122 | 2-Hydroxyisobutyrylation | YLSAALKKYQTEQRS HHHHHHHHHHHHHHC | 43.36 | - | |
| 125 | Phosphorylation | AALKKYQTEQRSKGD HHHHHHHHHHHCCCH | 30.88 | - | |
| 157 | Phosphorylation | GSKNPQKYSDKELQY CCCCCCCCCHHHHHH | 19.49 | 28152594 | |
| 157 (in isoform 4) | Phosphorylation | - | 19.49 | - | |
| 157 (in isoform 5) | Phosphorylation | - | 19.49 | - | |
| 158 | Phosphorylation | SKNPQKYSDKELQYI CCCCCCCCHHHHHHH | 49.60 | 28152594 | |
| 160 | Acetylation | NPQKYSDKELQYIDA CCCCCCHHHHHHHHH | 55.15 | 23236377 | |
| 160 | Ubiquitination | NPQKYSDKELQYIDA CCCCCCHHHHHHHHH | 55.15 | 21906983 | |
| 160 (in isoform 1) | Ubiquitination | - | 55.15 | 21906983 | |
| 160 (in isoform 2) | Ubiquitination | - | 55.15 | 21906983 | |
| 160 (in isoform 3) | Ubiquitination | - | 55.15 | 21906983 | |
| 160 (in isoform 4) | Ubiquitination | - | 55.15 | 21906983 | |
| 160 (in isoform 5) | Ubiquitination | - | 55.15 | 21906983 | |
| 160 (in isoform 6) | Ubiquitination | - | 55.15 | 21906983 | |
| 164 | Phosphorylation | YSDKELQYIDAISNK CCHHHHHHHHHHHCC | 17.25 | 21945579 | |
| 171 | Acetylation | YIDAISNKQGELENY HHHHHHCCCCHHHHH | 53.54 | 26051181 | |
| 171 | Ubiquitination | YIDAISNKQGELENY HHHHHHCCCCHHHHH | 53.54 | 21906983 | |
| 171 (in isoform 1) | Ubiquitination | - | 53.54 | 21906983 | |
| 171 (in isoform 2) | Ubiquitination | - | 53.54 | 21906983 | |
| 171 (in isoform 3) | Ubiquitination | - | 53.54 | 21906983 | |
| 171 (in isoform 4) | Ubiquitination | - | 53.54 | 21906983 | |
| 171 (in isoform 5) | Ubiquitination | - | 53.54 | 21906983 | |
| 171 (in isoform 6) | Ubiquitination | - | 53.54 | 21906983 | |
| 178 | Phosphorylation | KQGELENYVSDGYKT CCCHHHHHHCCCHHH | 7.61 | 25394399 | |
| 180 | Phosphorylation | GELENYVSDGYKTAL CHHHHHHCCCHHHHC | 18.24 | 29978859 | |
| 184 | Ubiquitination | NYVSDGYKTALTEER HHHCCCHHHHCHHHH | 32.62 | 21906983 | |
| 184 (in isoform 1) | Ubiquitination | - | 32.62 | 21906983 | |
| 184 (in isoform 2) | Ubiquitination | - | 32.62 | 21906983 | |
| 184 (in isoform 3) | Ubiquitination | - | 32.62 | 21906983 | |
| 184 (in isoform 4) | Ubiquitination | - | 32.62 | 21906983 | |
| 184 (in isoform 5) | Ubiquitination | - | 32.62 | 21906983 | |
| 184 (in isoform 6) | Ubiquitination | - | 32.62 | 21906983 | |
| 188 | Phosphorylation | DGYKTALTEERRRFC CCHHHHCHHHHHHHH | 33.08 | 27251275 | |
| 206 | Ubiquitination | EKQCAVAKNSAAYHS HHHHHHHCCCHHHHH | 44.85 | - | |
| 216 | Ubiquitination | AAYHSKGKELLAQKL HHHHHHCHHHHHHHC | 49.26 | - | |
| 235 | Ubiquitination | QACADPSKIPERAVQ HHHCCHHHCHHHHHH | 68.61 | - | |
| 249 | Phosphorylation | QLMQQVASNGATLPS HHHHHHHHCCCCCCH | 36.62 | 23403867 | |
| 253 | Phosphorylation | QVASNGATLPSALSA HHHHCCCCCCHHHHH | 40.37 | 28102081 | |
| 253 (in isoform 5) | Phosphorylation | - | 40.37 | 24719451 | |
| 256 | Phosphorylation | SNGATLPSALSASKS HCCCCCCHHHHHCCC | 44.98 | 29255136 | |
| 256 (in isoform 5) | Phosphorylation | - | 44.98 | 24719451 | |
| 259 | Phosphorylation | ATLPSALSASKSNLV CCCCHHHHHCCCCEE | 30.16 | 30266825 | |
| 261 | Phosphorylation | LPSALSASKSNLVIS CCHHHHHCCCCEEEC | 32.99 | 30266825 | |
| 261 (in isoform 4) | Phosphorylation | - | 32.99 | - | |
| 261 (in isoform 5) | Phosphorylation | - | 32.99 | 24719451 | |
| 263 | Phosphorylation | SALSASKSNLVISDP HHHHHCCCCEEECCC | 32.66 | 26657352 | |
| 275 | Ubiquitination | SDPIPGAKPLPVPPE CCCCCCCCCCCCCHH | 53.66 | 21906983 | |
| 275 (in isoform 1) | Ubiquitination | - | 53.66 | 21906983 | |
| 275 (in isoform 2) | Ubiquitination | - | 53.66 | 21906983 | |
| 275 (in isoform 3) | Ubiquitination | - | 53.66 | 21906983 | |
| 275 (in isoform 4) | Ubiquitination | - | 53.66 | 21906983 | |
| 275 (in isoform 5) | Ubiquitination | - | 53.66 | 21906983 | |
| 275 (in isoform 6) | Ubiquitination | - | 53.66 | 21906983 | |
| 291 | Phosphorylation | APFVGRMSAQESTPI HHHCCCCCCCCCCCC | 25.99 | 21945579 | |
| 291 (in isoform 5) | Phosphorylation | - | 25.99 | 24719451 | |
| 295 | Phosphorylation | GRMSAQESTPIMNGV CCCCCCCCCCCCCCC | 27.66 | 21945579 | |
| 295 (in isoform 5) | Phosphorylation | - | 27.66 | 24719451 | |
| 296 | Phosphorylation | RMSAQESTPIMNGVT CCCCCCCCCCCCCCC | 18.97 | 21945579 | |
| 296 (in isoform 4) | Phosphorylation | - | 18.97 | - | |
| 296 (in isoform 5) | Phosphorylation | - | 18.97 | - | |
| 303 | Phosphorylation | TPIMNGVTGPDGEDY CCCCCCCCCCCCCCC | 44.38 | 21945579 | |
| 310 | Phosphorylation | TGPDGEDYSPWADRK CCCCCCCCCHHHCCC | 16.60 | 21945579 | |
| 310 (in isoform 4) | Phosphorylation | - | 16.60 | - | |
| 310 (in isoform 5) | Phosphorylation | - | 16.60 | - | |
| 311 | Phosphorylation | GPDGEDYSPWADRKA CCCCCCCCHHHCCCC | 26.70 | 21945579 | |
| 311 (in isoform 4) | Phosphorylation | - | 26.70 | - | |
| 311 (in isoform 5) | Phosphorylation | - | 26.70 | - | |
| 322 | Ubiquitination | DRKAAQPKSLSPPQS CCCCCCCCCCCCCCH | 52.53 | - | |
| 323 | Phosphorylation | RKAAQPKSLSPPQSQ CCCCCCCCCCCCCHH | 40.54 | 30266825 | |
| 323 (in isoform 4) | Phosphorylation | - | 40.54 | - | |
| 323 (in isoform 5) | Phosphorylation | - | 40.54 | 24719451 | |
| 325 | Phosphorylation | AAQPKSLSPPQSQSK CCCCCCCCCCCHHHH | 41.44 | 25159151 | |
| 325 (in isoform 4) | Phosphorylation | - | 41.44 | - | |
| 325 (in isoform 5) | Phosphorylation | - | 41.44 | 24719451 | |
| 329 | Phosphorylation | KSLSPPQSQSKLSDS CCCCCCCHHHHCCCC | 42.04 | 30266825 | |
| 331 | Phosphorylation | LSPPQSQSKLSDSYS CCCCCHHHHCCCCCC | 40.59 | 23403867 | |
| 332 | Ubiquitination | SPPQSQSKLSDSYSN CCCCHHHHCCCCCCC | 44.36 | 21906983 | |
| 332 (in isoform 1) | Ubiquitination | - | 44.36 | 21906983 | |
| 332 (in isoform 2) | Ubiquitination | - | 44.36 | 21906983 | |
| 332 (in isoform 3) | Ubiquitination | - | 44.36 | 21906983 | |
| 332 (in isoform 4) | Ubiquitination | - | 44.36 | 21906983 | |
| 332 (in isoform 5) | Ubiquitination | - | 44.36 | 21906983 | |
| 332 (in isoform 6) | Ubiquitination | - | 44.36 | 21906983 | |
| 334 | Phosphorylation | PQSQSKLSDSYSNTL CCHHHHCCCCCCCCC | 28.39 | 21945579 | |
| 336 | Phosphorylation | SQSKLSDSYSNTLPV HHHHCCCCCCCCCCC | 27.38 | 21945579 | |
| 336 (in isoform 5) | Phosphorylation | - | 27.38 | 24719451 | |
| 337 | Phosphorylation | QSKLSDSYSNTLPVR HHHCCCCCCCCCCCC | 15.78 | 21945579 | |
| 338 | Phosphorylation | SKLSDSYSNTLPVRK HHCCCCCCCCCCCCC | 27.56 | 21945579 | |
| 338 (in isoform 4) | Phosphorylation | - | 27.56 | - | |
| 338 (in isoform 5) | Phosphorylation | - | 27.56 | 24719451 | |
| 340 | Phosphorylation | LSDSYSNTLPVRKSV CCCCCCCCCCCCCCC | 26.88 | 19664994 | |
| 340 (in isoform 4) | Phosphorylation | - | 26.88 | - | |
| 340 (in isoform 5) | Phosphorylation | - | 26.88 | 24719451 | |
| 346 | Phosphorylation | NTLPVRKSVTPKNSY CCCCCCCCCCCCCCC | 22.21 | 18669648 | |
| 346 (in isoform 4) | Phosphorylation | - | 22.21 | - | |
| 346 (in isoform 5) | Phosphorylation | - | 22.21 | 24719451 | |
| 348 | Phosphorylation | LPVRKSVTPKNSYAT CCCCCCCCCCCCCCC | 35.32 | 21712546 | |
| 348 (in isoform 4) | Phosphorylation | - | 35.32 | - | |
| 348 (in isoform 5) | Phosphorylation | - | 35.32 | 24719451 | |
| 350 | Ubiquitination | VRKSVTPKNSYATTE CCCCCCCCCCCCCCC | 49.51 | - | |
| 352 | Phosphorylation | KSVTPKNSYATTENK CCCCCCCCCCCCCCC | 23.44 | 25849741 | |
| 352 (in isoform 5) | Phosphorylation | - | 23.44 | 24719451 | |
| 353 | Phosphorylation | SVTPKNSYATTENKT CCCCCCCCCCCCCCC | 19.84 | 23927012 | |
| 355 | Phosphorylation | TPKNSYATTENKTLP CCCCCCCCCCCCCCC | 26.81 | 23927012 | |
| 356 | Phosphorylation | PKNSYATTENKTLPR CCCCCCCCCCCCCCC | 29.41 | 23927012 | |
| 359 | Ubiquitination | SYATTENKTLPRSSS CCCCCCCCCCCCCHH | 45.25 | 2190698 | |
| 359 (in isoform 1) | Ubiquitination | - | 45.25 | 21906983 | |
| 359 (in isoform 2) | Ubiquitination | - | 45.25 | 21906983 | |
| 359 (in isoform 3) | Ubiquitination | - | 45.25 | 21906983 | |
| 359 (in isoform 4) | Ubiquitination | - | 45.25 | 21906983 | |
| 359 (in isoform 5) | Ubiquitination | - | 45.25 | 21906983 | |
| 360 | Phosphorylation | YATTENKTLPRSSSM CCCCCCCCCCCCHHH | 54.28 | 23401153 | |
| 360 (in isoform 5) | Phosphorylation | - | 54.28 | 24719451 | |
| 364 | Phosphorylation | ENKTLPRSSSMAAGL CCCCCCCCHHHHHHC | 25.48 | 30266825 | |
| 365 | Phosphorylation | NKTLPRSSSMAAGLE CCCCCCCHHHHHHCH | 25.97 | 30266825 | |
| 366 | Phosphorylation | KTLPRSSSMAAGLER CCCCCCHHHHHHCHH | 17.43 | 19664994 | |
| 366 (in isoform 4) | Phosphorylation | - | 17.43 | - | |
| 366 (in isoform 5) | Phosphorylation | - | 17.43 | 24719451 | |
| 384 | Phosphorylation | MRVKAIFSHAAGDNS HHEEEEEECCCCCCC | 13.20 | 30266825 | |
| 391 | Phosphorylation | SHAAGDNSTLLSFKE ECCCCCCCEEEEECC | 25.77 | 30266825 | |
| 392 | Phosphorylation | HAAGDNSTLLSFKEG CCCCCCCEEEEECCC | 37.66 | 30266825 | |
| 392 (in isoform 5) | Phosphorylation | - | 37.66 | 24719451 | |
| 395 | Phosphorylation | GDNSTLLSFKEGDLI CCCCEEEEECCCCEE | 37.07 | 25849741 | |
| 395 (in isoform 5) | Phosphorylation | - | 37.07 | 24719451 | |
| 403 | Phosphorylation | FKEGDLITLLVPEAR ECCCCEEEEEEECCC | 22.72 | 24732914 | |
| 432 | Phosphorylation | GWFPFSYTRVLDSDG CEECCEEEEEECCCC | 17.07 | - | |
| 437 | Phosphorylation | SYTRVLDSDGSDRLH EEEEEECCCCCCCCE | 39.44 | 28857561 | |
| 440 | Phosphorylation | RVLDSDGSDRLHMSL EEECCCCCCCCEEEE | 25.25 | 28985074 | |
| 440 (in isoform 5) | Phosphorylation | - | 25.25 | 24719451 | |
| 446 | Phosphorylation | GSDRLHMSLQQGKSS CCCCCEEEECCCCCC | 16.57 | 28857561 | |
| 446 (in isoform 5) | Phosphorylation | - | 16.57 | 24719451 | |
| 452 | Phosphorylation | MSLQQGKSSSTGNLL EEECCCCCCCCCCCC | 36.02 | 30266825 | |
| 452 (in isoform 4) | Phosphorylation | - | 36.02 | - | |
| 452 (in isoform 5) | Phosphorylation | - | 36.02 | 24719451 | |
| 453 | Phosphorylation | SLQQGKSSSTGNLLD EECCCCCCCCCCCCC | 35.09 | 30266825 | |
| 453 (in isoform 4) | Phosphorylation | - | 35.09 | - | |
| 453 (in isoform 5) | Phosphorylation | - | 35.09 | - | |
| 454 | Phosphorylation | LQQGKSSSTGNLLDK ECCCCCCCCCCCCCH | 47.64 | 25159151 | |
| 454 (in isoform 4) | Phosphorylation | - | 47.64 | - | |
| 454 (in isoform 5) | Phosphorylation | - | 47.64 | - | |
| 455 | Phosphorylation | QQGKSSSTGNLLDKD CCCCCCCCCCCCCHH | 31.85 | 30266825 | |
| 455 (in isoform 4) | Phosphorylation | - | 31.85 | - | |
| 455 (in isoform 5) | Phosphorylation | - | 31.85 | - | |
| 471 | Phosphorylation | LAIPPPDYGAASRAF CCCCCCCCCHHHCCC | 17.90 | 28152594 | |
| 471 (in isoform 4) | Phosphorylation | - | 17.90 | - | |
| 471 (in isoform 5) | Phosphorylation | - | 17.90 | - | |
| 475 | Phosphorylation | PPDYGAASRAFPAQT CCCCCHHHCCCCCCC | 24.49 | 28152594 | |
| 482 | Phosphorylation | SRAFPAQTASGFKQR HCCCCCCCCCCCCCC | 25.54 | 29396449 | |
| 484 | Phosphorylation | AFPAQTASGFKQRPY CCCCCCCCCCCCCCC | 48.42 | 25159151 | |
| 484 (in isoform 5) | Phosphorylation | - | 48.42 | 24719451 | |
| 491 | Phosphorylation | SGFKQRPYSVAVPAF CCCCCCCCEEECCCC | 20.26 | 21945579 | |
| 492 | Phosphorylation | GFKQRPYSVAVPAFS CCCCCCCEEECCCCC | 13.29 | 21945579 | |
| 492 (in isoform 5) | Phosphorylation | - | 13.29 | 24719451 | |
| 499 | Phosphorylation | SVAVPAFSQGLDDYG EEECCCCCCCCCCCC | 25.99 | 21945579 | |
| 499 (in isoform 4) | Phosphorylation | - | 25.99 | - | |
| 499 (in isoform 5) | Phosphorylation | - | 25.99 | 24719451 | |
| 505 | Phosphorylation | FSQGLDDYGARSMSR CCCCCCCCCCCCCCC | 16.61 | 21945579 | |
| 509 | Phosphorylation | LDDYGARSMSRNPFA CCCCCCCCCCCCCCC | 22.15 | 28555341 | |
| 509 (in isoform 4) | Phosphorylation | - | 22.15 | 27251275 | |
| 509 (in isoform 5) | Phosphorylation | - | 22.15 | 25849741 | |
| 510 (in isoform 6) | Phosphorylation | - | 3.48 | 27251275 | |
| 511 (in isoform 4) | Phosphorylation | - | 30.10 | 30266825 | |
| 511 (in isoform 5) | Phosphorylation | - | 30.10 | 25849741 | |
| 512 (in isoform 4) | Phosphorylation | - | 46.31 | 30266825 | |
| 512 (in isoform 5) | Phosphorylation | - | 46.31 | 22617229 | |
| 512 (in isoform 6) | Phosphorylation | - | 46.31 | 30266825 | |
| 513 (in isoform 6) | Phosphorylation | - | 28.83 | 30266825 | |
| 514 (in isoform 4) | Phosphorylation | - | 27.05 | 30266825 | |
| 515 (in isoform 6) | Phosphorylation | - | 9.31 | 30266825 | |
| 516 (in isoform 4) | Phosphorylation | - | 11.82 | 30266825 | |
| 517 (in isoform 6) | Phosphorylation | - | 14.29 | 30266825 | |
| 519 (in isoform 4) | Phosphorylation | - | 33.62 | 23090842 | |
| 520 (in isoform 4) | Phosphorylation | - | 7.54 | 28355574 | |
| 520 (in isoform 6) | Phosphorylation | - | 7.54 | 23090842 | |
| 521 (in isoform 6) | Phosphorylation | - | 22.88 | 28355574 | |
| 523 | Phosphorylation | AHVQLKPTVTNDRCD CEEEECCCCCCCCCC | 38.07 | 26437602 | |
| 523 (in isoform 2) | Phosphorylation | - | 38.07 | 27251275 | |
| 525 (in isoform 2) | Phosphorylation | - | 33.60 | 27251275 | |
| 529 (in isoform 2) | Phosphorylation | - | 7.42 | 27251275 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BAIP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BAIP2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-325 AND SER-454, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-296; TYR-310; SER-323;SER-325; SER-346; THR-348 AND SER-366, AND MASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-325, AND MASSSPECTROMETRY. | |
| "Dentatorubral-pallidoluysian atrophy protein interacts through aproline-rich region near polyglutamine with the SH3 domain of aninsulin receptor tyrosine kinase substrate."; Okamura-Oho Y., Miyashita T., Ohmi K., Yamada M.; Hum. Mol. Genet. 8:947-957(1999). Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 4), PHOSPHORYLATION ATTYROSINE RESIDUES, SUBCELLULAR LOCATION, INTERACTION WITH ATN1, ANDTISSUE SPECIFICITY. | |
| "An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-337, AND MASSSPECTROMETRY. | |
| "Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-157, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-337; TYR-491 ANDTYR-505, AND MASS SPECTROMETRY. | |